Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?

Gastroenterology. 2021 Mar;160(4):1423-1424. doi: 10.1053/j.gastro.2020.12.013. Epub 2020 Dec 11.

Authors

Andrea Casadei-Gardini¹, Stefano Cascinu¹, Massimo Colombo²

Affiliations

¹ School of Medicine, Vita-Salute San Raffaele University and, Unit of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
² Liver Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.

PMID: 33310087
DOI: 10.1053/j.gastro.2020.12.013

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Bevacizumab
Carcinoma, Hepatocellular* / drug therapy
Humans
Liver Neoplasms* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
Bevacizumab
atezolizumab